spironolactone has been researched along with lisinopril in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (38.71) | 29.6817 |
| 2010's | 17 (54.84) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bellorini, M; Desnos, M; Duboc, D; Funck, F; Guillard, N; Jourdain, P; Loiret, J; Thebault, B | 1 |
| Chapon, C; Furber, A; Kreher, P; Le Bouil, A; Marescaux, L; Rochetaing, A | 1 |
| Challande, P; Delcayre, C; Labat, C; Lacolley, P; Leenhardt, A; Milliez, P; Nehme, JA; Perret, C; Robidel, E; Safar, ME | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Ahn, J; Frohlich, ED; Matavelli, LC; Susic, D; Varagic, J | 1 |
| Altenberger, H; Finsterer, J; Stöllberger, C | 1 |
| Parker, T | 1 |
| Gutiérrez Solís, E; Gutiérrez, E; Huerta, A; Morales, E; Praga, M; Segura, J | 1 |
| Briganti, C; Caulo, M; Notturno, F; Tartaro, A; Uncini, A | 1 |
| Adams-Huet, B; Mehdi, UF; Raskin, P; Toto, RD; Vega, GL | 1 |
| Adefehinti, O; Adelusola, KA; Olowu, WA | 1 |
| Canan, BD; Chimanji, NS; Delfín, DA; Ganguly, R; Janssen, PM; Martin, CD; Mays, TA; Murray, JD; Rafael-Fortney, JA; Raman, SV; Schill, KE; Stangland, JE; Tran, T; Xu, Y | 1 |
| Fayssoil, A | 1 |
| Ahmad, T; Milano, CA; Patel, CB; Rogers, JG | 1 |
| Handler, J | 1 |
| Adams-Huet, B; Molina, C; Nguyen, M; Toto, RD; Van Buren, PN | 1 |
| Fried, LF; Seliger, SL | 1 |
| Janssen, PM; Murray, JD; Rafael-Fortney, JA; Raman, SV; Rastogi, N; Schill, KE; Schultz, EJ; Tran, T | 1 |
| Chadwick, JA; Gomez-Sanchez, CE; Gomez-Sanchez, EP; Guttridge, DC; Hauck, JS; Lowe, J; Rafael-Fortney, JA; Shaw, JJ | 1 |
| Chadwick, JA; Floyd, KT; Gomez-Sanchez, CE; Gomez-Sanchez, EP; Janssen, PM; Kadakia, FK; Lowe, J; Rafael-Fortney, JA; Raman, SV; Rastogi, N; Schultz, EJ; Smart, S; Swager, SA; Zins, JG | 1 |
| Bhattacharya, S; Chadwick, JA; Lowe, J; Rafael-Fortney, JA; Weisleder, N | 1 |
| Paulus, R; Schmidt, B | 1 |
| Booz, C; Buchner, K; Eichler, K; Frey, N; Gruber-Rouh, T; Gruenewald, LD; Hagenmueller, M; Hardt, SE; Koch, V; Martin, S; März, W; Riffel, JH; Vogl, TJ; Yel, I | 1 |
1 review(s) available for spironolactone and lisinopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for spironolactone and lisinopril
| Article | Year |
|---|---|
[The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? ].
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Eplerenone; Female; Humans; Lisinopril; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Obesity; Prospective Studies; Proteinuria; Spironolactone; Tetrazoles | 2009 |
Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bicarbonates; Blood Pressure; Creatinine; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypertension; Lisinopril; Losartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Renin-Angiotensin System; Spironolactone | 2009 |
Potassium handling with dual renin-angiotensin system inhibition in diabetic nephropathy.
Topics: Adult; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Lisinopril; Losartan; Male; Middle Aged; Potassium; Prospective Studies; Renin-Angiotensin System; Risk Factors; Sodium; Spironolactone; Texas; Time Factors; Treatment Outcome | 2014 |
27 other study(ies) available for spironolactone and lisinopril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Follow-Up Studies; France; Furosemide; Heart Failure; Humans; Incidence; Lisinopril; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Severity of Illness Index; Spironolactone; Stroke Volume; Treatment Outcome | 2003 |
Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
Topics: Action Potentials; Animals; Cardiotonic Agents; Coronary Circulation; Drug Therapy, Combination; Electrophysiologic Techniques, Cardiac; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Norepinephrine; Potassium; Rats; Rats, Wistar; Spironolactone; Ventricular Function, Left | 2003 |
Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure.
Topics: Animals; Carotid Arteries; Compliance; Drug Therapy, Combination; Echocardiography; Elasticity; Fibrosis; Heart Failure; Lisinopril; Male; Myocardial Ischemia; Random Allocation; Rats; Rats, Wistar; Spironolactone; Time Factors; Ventricular Function, Left | 2005 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Beneficial cardiovascular actions of eplerenone in the spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Coronary Circulation; Eplerenone; Hypertension; Lisinopril; Male; Rats; Rats, Inbred SHR; Spironolactone; Vascular Resistance | 2005 |
Isolated left ventricular hypertrabeculation/noncompaction in a Turner mosaic with male phenotype.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Digoxin; Diuretics; Echocardiography; Furosemide; Heart Ventricles; Humans; Lisinopril; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Mosaicism; Phenotype; Propanolamines; Spironolactone; Turner Syndrome; Ventricular Dysfunction, Left | 2009 |
Case of the month. Idiopathic dilated cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiography; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Clopidogrel; Diuretics; Dyspnea; Echocardiography; Electrocardiography; Furosemide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Potassium; Propanolamines; Pyrroles; Spironolactone; Ticlopidine | 2009 |
Asymptomatic spinal cord involvement in posterior reversible encephalopathy syndrome.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cervical Vertebrae; Female; Humans; Lisinopril; Posterior Leukoencephalopathy Syndrome; Spinal Cord; Spironolactone; Treatment Outcome | 2009 |
Childhood idiopathic steroid resistant nephrotic syndrome in Southwestern Nigeria.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Lisinopril; Male; Mineralocorticoid Receptor Antagonists; Nephrotic Syndrome; Nigeria; Prevalence; Pulse Therapy, Drug; Recurrence; Regression Analysis; Retrospective Studies; Spironolactone; Steroids; Time Factors; Treatment Failure | 2010 |
Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.
Topics: Animals; Cardiac Imaging Techniques; Cardiomyopathies; Cardiotonic Agents; Disease Models, Animal; Diuretics; Isoproterenol; Lisinopril; Magnetic Resonance Imaging; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myocardium; Spironolactone | 2011 |
Letter by Fayssoil regarding article, "Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice".
Topics: Animals; Lisinopril; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myocardium; Spironolactone | 2012 |
When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiotonic Agents; Carvedilol; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Furosemide; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Lisinopril; Male; Middle Aged; Milrinone; Propanolamines; Severity of Illness Index; Spironolactone | 2012 |
Commentary in support of a highly effective hypertension treatment algorithm.
Topics: Adult; Algorithms; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Spironolactone; Treatment Outcome; United States | 2013 |
Serum potassium in dual renin-angiotensin-aldosterone system blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Diuretics; Female; Humans; Lisinopril; Losartan; Male; Potassium; Renin-Angiotensin System; Spironolactone | 2014 |
Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Diuretics; Dystrophin; Female; Gene Expression; Glucocorticoids; Humans; Lisinopril; Losartan; Male; Mice; Mice, Inbred mdx; Muscle Contraction; Muscle Weakness; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Myocardium; Prednisolone; Spironolactone; Utrophin | 2014 |
Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target.
Topics: Aldosterone; Animals; Cell Line; Humans; Lisinopril; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Diseases; Receptors, Melanocortin; Spironolactone | 2015 |
Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Eplerenone; Gene Knockdown Techniques; Heart; Lisinopril; Male; Mice; Mice, Inbred mdx; Mineralocorticoid Receptor Antagonists; Muscle, Skeletal; Muscular Dystrophy, Animal; Myocardium; Spironolactone; Treatment Outcome; Utrophin | 2016 |
Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Membrane; Dose-Response Relationship, Drug; Gene Expression Regulation; Lisinopril; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Muscle Proteins; Muscular Dystrophies; Renin-Angiotensin System; Spironolactone; Treatment Outcome | 2017 |
90-year-old man • dyspnea • lower extremity edema • limitations in daily activities • Dx?
Topics: Activities of Daily Living; Aged, 80 and over; Diagnosis, Differential; Diuretics; Dyspnea; Edema; Female; Heart Failure; Humans; Lisinopril; Lower Extremity; Metoprolol; Obesity; Spironolactone; Torsemide | 2020 |
Homoarginine treatment of rats improves cardiac function and remodeling in response to pressure overload.
Topics: Animals; Blood Pressure; Heart Failure; Homoarginine; Hypertension; Lisinopril; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Spironolactone; Ventricular Remodeling | 2022 |